An Analysis of Treatment Timelines for Lung Cancer Patients Across System Evolutions

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03535766

Acronym

TRACE

Enrollment

2100

Registered

2018-05-24

Start date

2018-03-01

Completion date

2023-01-09

Last updated

2024-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Brief summary

This study is a single center, minimal risk, physician initiated retrospective chart review. An analysis of treatment timelines for patients diagnosed with lung cancer within the St. Elizabeth system from January 2013 until study completion. The study investigator and designee(s) will review patient electronic medical records, extracting data related to the symptom presentation, diagnosis, and treatment of new diagnoses of lung cancer. Collected data will focus on dates of encounters, diagnostic imaging/procedures, and treatments, with data analysis evaluating time between care encounters and potential delays in care. The data will be further stratified based on system-wide changes implemented to improve efficiency, patient outcomes, and patient experience.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient seen within the St. Elizabeth system * \>=18 years of age * New diagnosis of histologically or cytologically documented primary lung cancer diagnosed January 2013 or later

Exclusion criteria

* Patients with metastatic lung disease of other primary * Other malignancies at investigator's discretion * Patient received treatment at a facility outside of St. Elizabeth where records are not available through EPIC * Patient currently undergoing treatment for new diagnosis of lung cancer

Design outcomes

Primary

Measure	Time frame	Description
Time from presentation to treatment	from initial patient presentation with symptoms or incidental finding to first day of treatment, up to 3 years	Time from initial patient presentation with symptoms or incidental finding to first day of treatment, measured in days.

Secondary

Measure	Time frame
Additional time between imaging and physician referrals	From identification of concerning nodule to specialist appointment, up to 3 years

Countries

United States

Outcome results